Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study.

BMC gastroenterology - 7 Dec 2021

Eshraghian Ahad, Moasser Elham, Azarpira Negar, Fattahi Mohammad Reza, Nikeghbalian Saman, Malek-Hosseini Seyed Ali, Geramizadeh Bita

Abstract excerpt

BACKGROUND: Genetic abnormalities might have important role in pathogenesis of hepatic steatosis after liver transplantation. We aimed to investigate association between genetic variations in transmembrane 6 superfamily member 2 (TM6SF2) rs58542926, proprotein convertase subtilisin/kexin type 9 (PCSK9) rs505151 and proprotein convertase subtilisin/kexin type 7 (PCSK7) rs2277287 with hepatic steatosis in liver...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross-Sectional Studies
Share to Genotype
Share to Liver Transplantation
Share to Membrane Proteins
Share to Non-alcoholic Fatty Liver Disease
Share to Polymorphism, Single Nucleotide
Share to Proprotein Convertase 9
Share to Subtilisins

Source

Open in PubMed Open full text

Identifiers

PMID: 34876018
DOI: 10.1186/s12876-021-02041-8
PMCID: PMC8650293

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study.PMID 34876018Read ↗

Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver TransplantationSemantic proximity Read ↗

Research progress on the relationship between TM6SF2 rs58542926 polymorphism and non-alcoholic fatty liver disease.Semantic proximity Read ↗

TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis.Semantic proximity Read ↗

TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and CirrhosisSemantic proximity Read ↗

Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patientsSemantic proximity Read ↗

Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes.Semantic proximity Read ↗

Association between TM6SF2 rs58542926 T/C gene polymorphism and significant liver fibrosis: A meta-analysisSemantic proximity Read ↗

The impact of transmembrane 6 superfamily 2 (TM6SF2) rs58542926 on liver-related events in patients with advanced chronic liver disease.Semantic proximity Read ↗

Genetic Risk Factors for Steatotic Liver Disease After Liver Transplantation.Semantic proximity Read ↗

The impact of PNPLA3 and TM6SF2 in cirrhosis related complicationsSemantic proximity Read ↗

The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis.Semantic proximity Read ↗

MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.